JPS5785369A - Quinolone, therapeutical composition containing same and manufacture - Google Patents

Quinolone, therapeutical composition containing same and manufacture

Info

Publication number
JPS5785369A
JPS5785369A JP56151895A JP15189581A JPS5785369A JP S5785369 A JPS5785369 A JP S5785369A JP 56151895 A JP56151895 A JP 56151895A JP 15189581 A JP15189581 A JP 15189581A JP S5785369 A JPS5785369 A JP S5785369A
Authority
JP
Japan
Prior art keywords
quinolone
manufacture
composition containing
containing same
therapeutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56151895A
Other languages
English (en)
Other versions
JPS6348268B2 (ja
Inventor
Bikutaa Deebisu Roi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of JPS5785369A publication Critical patent/JPS5785369A/ja
Publication of JPS6348268B2 publication Critical patent/JPS6348268B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
JP56151895A 1980-09-26 1981-09-25 Quinolone, therapeutical composition containing same and manufacture Granted JPS5785369A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8031106 1980-09-26

Publications (2)

Publication Number Publication Date
JPS5785369A true JPS5785369A (en) 1982-05-28
JPS6348268B2 JPS6348268B2 (ja) 1988-09-28

Family

ID=10516302

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56151895A Granted JPS5785369A (en) 1980-09-26 1981-09-25 Quinolone, therapeutical composition containing same and manufacture

Country Status (4)

Country Link
JP (1) JPS5785369A (ja)
BE (1) BE890477A (ja)
HU (1) HU184968B (ja)
ZA (1) ZA816352B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03196382A (ja) * 1989-12-26 1991-08-27 Nec Home Electron Ltd 携帯型情報処理装置

Also Published As

Publication number Publication date
JPS6348268B2 (ja) 1988-09-28
HU184968B (en) 1984-11-28
BE890477A (fr) 1982-03-24
ZA816352B (en) 1982-09-29

Similar Documents

Publication Publication Date Title
JPS5777616A (en) Medicinal composition and manufacture
JPS56167689A (en) Beta-lactam compounds, their manufacture and use
JPS5798281A (en) Azabicyclooctane-carboxylic acid, manufacture and pharmaceutical composition containing same
JPS5716868A (en) 1-hydroxyethyl-azole derivative,manufacture and use
JPS5731689A (en) Substituted benzamide, manufacture and medicinal composition containing same
JPS5785383A (en) Benzofuranylethanol amine derivative, manufacture and medicinal composition containing same
JPS5756478A (en) Triazinylaminotriazines, manufacture and use
JPS56158780A (en) Substituted dibenzooxepine, its manufacture and composition
JPS5795971A (en) Compound, manufacture and use
JPS56131539A (en) Substituted bromfluorobenzene and manufacture
JPS56120392A (en) Novel composition and its manufacture
JPS5795973A (en) Compound, manufacture and use
JPS5748993A (en) N-phosphonylcarbonyl-carbamates, manufacture and use
JPS5750990A (en) Condensed as-triazine derivative, manufacture and medicinal composition containing same
JPS5724365A (en) Antitumoral compound, manufacture and medicinal composition containing same
JPS5781493A (en) Ammoniomethyl compound, manufacture and medicinal composition containing same
JPS56139479A (en) Quinoline derivative, manufacture and medicinal composition containing same
JPS5795974A (en) Compound, manufacture and use
JPS56147728A (en) Novel compound, its manufacture and use
JPS56139482A (en) 3-chloro-quinoline derivative, manufacture and medicinal composition
JPS5774362A (en) Anthraquinone-azo compound, manufacture and use
JPS5724339A (en) Alkoxy-acylcarnitine, manufacture and medicinal composition as effective component thereof
JPS57122077A (en) Dihydropyranes, manufacture and use
JPS5785369A (en) Quinolone, therapeutical composition containing same and manufacture
JPS5795968A (en) Trichloromethylquinoxalines, manufacture and use